Blockbuster Biologics Review, produced by our intellectual property lawyers, covers developments in inter partes review (IPR) and patent litigation challenges to blockbuster biologic drugs.
These quarterly reports provide updates on the following topics:
We will continue to monitor developments and provide updates regularly.
2024
2023
2022
2021
2020
2019
2018
News
Thought Leadership